12.06.2014 • News

Former Novartis Employee Suspected of Data Manipulation

A former employee of Novartis Pharma KK, the Japan unit of the Swiss drugmaker, has been arrested on suspicion of manipulating data to promote the company's best-selling blood pressure drug Diovan.

Nobuo Shiraishi is suspected of violating Japan's pharmaceutical laws by providing false data to researchers, whose work was intended for use in advertising the drug, the Tokyo District Public Prosecutor's Office said in a statement.

Novartis Pharma KK said it would cooperate with the investigation.

Anyone found guilty of exaggerated advertising of drugs in Japan can be punished with up to two years in prison or a fine of as much as 2 million yen ($19,600), or both.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.